STOCK TITAN

CCC Intelligent Solutions Holdings Inc. 10-Q Filings

CCCS NASDAQ

Every 10-Q that CCC Intelligent Solutions Holdings Inc. (CCCS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow CCCS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CCCS filings page.

Rhea-AI Summary

CCC Intelligent Solutions Holdings Inc. reported stronger results for the quarter ended March 31, 2026. Revenue reached $281.3 million, up from $251.6 million a year earlier, driving gross profit of $208.9 million.

The company generated operating income of $48.8 million versus a prior-year operating loss and net income attributable to common stockholders of $15.4 million, or $0.03 per diluted share, compared with a $0.03 loss per share last year. Operating cash flow was $57.5 million.

CCC ended the quarter with $36.9 million in cash and cash equivalents and a Term Loan balance of about $1.29 billion. It continued returning capital to stockholders, repurchasing 16.6 million shares for $100.0 million under its 2025 Share Repurchase Program, and it has $100.0 million of authorization remaining.

Rhea-AI Summary

CCC Intelligent Solutions (CCCS) reported Q3 results and detailed the integration of EvolutionIQ. Revenue was $267.1 million, up from $238.5 million a year ago, with operating income of $30.0 million. A net loss of $2.0 million reflected a $15.4 million income tax provision that exceeded pretax income.

Year-to-date, revenue reached $779.1 million with operating cash flow of $196.3 million. The company closed the EvolutionIQ acquisition for $674.3 million (cash and stock), adding $538.8 million of goodwill and $167.9 million of intangibles. Cash and equivalents were $97.1 million, down from $399.0 million at year-end, reflecting the acquisition and share repurchases.

Long-term financing was updated via a $993.5 million term loan maturing in 2032, and CCCS entered interest-rate swaps starting July 2025 that fix payments on $750.0 million at 3.94% through 2027. Remaining performance obligations totaled $1.741 billion, with $752 million expected over the next twelve months. Shares outstanding were 647,182,603 as of September 30, 2025.